OptimizeRx Announces Results from use of AI/RWE Solution
Analysis demonstrates effectiveness of OptimizeRx’s real-world evidence solution to identify patients suitable for a specialty therapy within a narrow timeframe OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a...
